|
🐜
|
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
19 auth.
Zheng Wang,
Z. Ren,
Yi Chen,
Jie Hu,
Guohuan Yang,
Lei Yu,
Xinrong Yang,
Ao Huang,
Xin Zhang,
Shaolai Zhou,
...
Huichuan Sun,
Yan‐hong Wang,
N. Ge,
Xiaoyu Xu,
Zhao-You Tang,
Wanyee Lau,
Jia Fan,
Jiping Wang,
Jian Zhou
|
7 |
2018 |
7
🐜
|
|
🐢
|
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study
Zhe Zhang,
Xiaoping Zhou,
Hu-jia Shen,
De-xing Wang,
Yan‐hong Wang
|
7 |
2009 |
7
🐢
|
|
🐜
|
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma
9 auth.
Xin Yin,
Lan Zhang,
Yan‐hong Wang,
Bo‐heng Zhang,
Y. Gan,
N. Ge,
...
Yi Chen,
Li-xin Li,
Z. Ren
|
6 |
2014 |
6
🐜
|
|
🐜
|
Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells
14 auth.
Yang You,
Qiongdan Zheng,
Yinying Dong,
Xiaoying Xie,
Yaohui Wang,
Sifan Wu,
Lan Zhang,
Yingcong Wang,
Tong-Chun Xue,
Zhiming Wang,
...
Rongxin Chen,
Yan‐hong Wang,
Jiefeng Cui,
Z. Ren
|
6 |
2016 |
6
🐜
|
|
🐜
|
γ-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma
12 auth.
Hui-Jen Ma,
Lan Zhang,
B. Tang,
Yan Wang,
Rongxin Chen,
Boheng Zhang,
...
Yi Chen,
N. Ge,
Yan‐hong Wang,
Y. Gan,
S. Ye,
Z. Ren
|
6 |
2014 |
6
🐜
|
|
🐜
|
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization
13 auth.
Yan Wang,
Yi Chen,
N. Ge,
Lan Zhang,
Xiaoying Xie,
Ju-bo Zhang,
Rongxin Chen,
Yan‐hong Wang,
Boheng Zhang,
J. Xia,
...
Y. Gan,
Z. Ren,
S. Ye
|
5 |
2012 |
5
🐜
|
|
🐜
|
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study
11 auth.
Tong-Chun Xue,
Fan Le,
Rongxin Chen,
Xiaoying Xie,
Lan Zhang,
N. Ge,
...
Yi Chen,
Yan‐hong Wang,
Boheng Zhang,
S. Ye,
Z. Ren
|
5 |
2015 |
5
🐜
|
|
🐜
|
Risk factors for recurrence of small hepatocellular carcinoma after long-term follow-up of percutaneous radiofrequency ablation.
14 auth.
Biwei Yang,
Jing-Huai Zou,
J. Xia,
Z. Ren,
Y. Gan,
Yan‐hong Wang,
Boheng Zhang,
N. Ge,
D. Wang,
Yi Chen,
...
Rongxin Chen,
Li-xin Li,
S. Ye,
Xiangdong Wang
|
5 |
2011 |
5
🐜
|
|
🐜
|
The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization
7 auth.
Tong-Chun Xue,
Qing-an Jia,
N. Ge,
Bo‐heng Zhang,
Yan‐hong Wang,
Z. Ren,
...
S. Ye
|
5 |
2015 |
5
🐜
|
